{"url_path":"/sec/mgrx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1938046/0001493152-26-024426-index.html","accession_number":"0001493152-26-024426","cik":"0001938046","ticker":"MGRX","issuer_name":"MANGOCEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1938046/0001493152-26-024426-index.html","primary_entity_key":"0001938046","primary_entity_name":"MANGOCEUTICALS, INC."},"word_count":310,"has_tables":true,"body_markdown":"Item\n6. Exhibits\n\n \n\nThe\nfollowing exhibits are filed herewith or incorporated by reference herein:\n\n \n\n** **\n \n** **\n** **\n**Incorporated\nby Reference**\n\n**Exhibit\nNumber**\n \n**Description\nof Exhibit**\n** **\n\n**Filed/**\n\n**Furnished\nHerewith**\n\n \n**Form**\n \n**Exhibit**\n** **\n**Filing\nDate**\n \n**File\nNumber**\n\n10.1#\n \n[Mangoceuticals, Inc. Amendment to Stock Option Agreements (Jacob Cohen), dated March 16, 2026](https://www.sec.gov/Archives/edgar/data/1938046/000164117225000525/ex10-1.htm)\n\n-\n \n8-K\n \n10.1\n \n3/25/2025\n \n001-41615\n\n10.2#*\n\n \n[Clarification Agreement dated May 18, 2026, entered into between Mangoceuticals, Inc. and Jacob Cohen](ex10-2.htm)\n \nX\n \n \n \n \n \n \n \n \n\n31.1*\n \n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act](ex31-1.htm)\n \nX\n \n \n \n \n \n \n \n \n\n31.2*\n \n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act](ex31-2.htm)\n \nX\n \n \n \n \n \n \n \n \n\n32.1**\n \n[Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](ex32-1.htm)\n \nX\n \n \n \n \n \n \n \n \n\n32.2**\n \n[Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act](ex32-2.htm)\n \nX\n \n \n \n \n \n \n \n \n\n101.INS*\n \nInline\nXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within\nthe Inline XBRL document\n \nX\n \n \n \n \n \n \n \n \n\n101.SCH*\n \nInline\nXBRL Taxonomy Extension Schema Document\n \nX\n \n \n \n \n \n \n \n \n\n101.CAL*\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n \nX\n \n \n \n \n \n \n \n \n\n101.DEF*\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n \nX\n \n \n \n \n \n \n \n \n\n101.LAB*\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n \nX\n \n \n \n \n \n \n \n \n\n101.PRE*\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n \nX\n \n \n \n \n \n \n \n \n\n104*\n \nInline\nXBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set\n \nX\n \n \n \n \n \n \n \n \n\n** **\n\n*\nFiled herewith.\n\n \n\n**\nFurnished herewith.\n\n \n\n#\nIndicates management contract or compensatory plan or arrangement.\n\n \n\n65\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its\nbehalf by the undersigned thereunto duly authorized.\n\n \n\n \n**Mangoceuticals,\nInc.**\n\n \n \n \n\nDate:\nMay 19, 2026\nBy:\n*/s/\nJacob D. Cohen*\n\n \n \nJacob\nD. Cohen\n\n \n \nChief\nExecutive Officer\n\n \n \n(Principal\nExecutive Officer)\n\n \n \n \n\nDate:\nMay 19, 2026\nBy:\n*/s/\nEugene M. Johnston*\n\n \n \nEugene\nM. Johnston\n\n \n \nChief\nFinancial Officer\n\n \n \n(Principal\nFinancial and Accounting Officer)\n\n \n\n66"}